Adcock Ingram’s turnover rose 6% to R9.6bn, driven by demand for winter cold and flu medicines. HEPS grew 10%, with the final dividend rising to 275 cents.
High winter product demand lifts Adcock Ingram’s turnover
Original Article by Kabelo Khumalo | Business Day | 23 August 2024
Adcock Ingram's turnover rose 6% to R9.6bn, driven by demand for winter cold and flu medicines. HEPS grew 10%, with the final dividend rising to 275 cents.
More Posts
Thembisile Xulu Named New Health Director-General
Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.
Read more...
Gauteng Nurse Shortage Deepens, Threatening NHI Rollout
Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.
Read more...
Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options
Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.
Read more...